A small pilot study involving 25 participants was initiated for Sigknow Biomedical’s first product EZYPRO® ECG Recorder, at Shin Kong Wu Ho-Su Memorial Hospital in the fourth quarter of 2017. The main objective of the study was to compare a 24-hour Holter monitor with EZYPRO® in terms of arrhythmia events and patient compliance during the wearing time.

Sigknow Biomedical’s EZYPRO® will launch a large-scale clinical trial at Linkou Chang Gung Memorial Hospital and Taipei Veterans General Hospital. The project is expected to involve 150 participants. It will compare a 24-hour Holter monitor with EZYPRO® in terms of arrhythmia events and patient compliance during the wearing time. The clinical trial will be initiated in February 2018.